| Pharmaceutical active ingredients: |
| Apomorphine Hydrochloride |
| Available forms, composition and doses of Britaject: |
| N / A |
| Britaject medical category: |
| Human:Non-selective dopamine agonists |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G04BE07 - ApomorphineN04BC07 - Apomorphine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Eli LillyBritannia Pharmaceuticals |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
APO-Go Pen | Apomorphine Hydrochloride | Britannia Pharmaceuticals; ITF Farma; Sandoz |
| APO-Go PFS | Apomorphine Hydrochloride | Britannia Pharmaceuticals |
| Apokinon | Apomorphine Hydrochloride | Aguettant; Rontag Laboratorios |
| Apokyn | Apomorphine Hydrochloride | Mylan; Ipsen Pharma; Tercica |
| Apomine | Apomorphine Hydrochloride | Mayne Pharma |
| Ixense | Apomorphine Hydrochloride | Takeda Pharmaceutical |
| Noc | Apomorphine Hydrochloride | Recalcine Laboratorios |
| Taluvian | Apomorphine Hydrochloride | Abbott; Armstrong Laboratorios de Mexico; Esteve Farma |
| Uprima | Apomorphine Hydrochloride | Abbott |
| Travella | Apomorphine; Cocculus; Nux Vomica; Petroleum; Staphisagria; Tabacum; Theridion | A. Nelson & Co. |